Presentation is loading. Please wait.

Presentation is loading. Please wait.

Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute.

Similar presentations


Presentation on theme: "Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute."— Presentation transcript:

1 Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute

2 Description The Cancer Prevention and Control Research Network (CPCRN) is actively engaged in advancing both the science and practice of cancer control through scholarly activities and community engagement. Several of our multicenter activities (completed and in progress) emphasize filling evidence gaps related to cancer prevention and control.

3 Review Paper of IDM Measures Mullen PD, Allen JD, Glanz K, Fernandez ME, Bowen DJ, Pruitt SL, Glenn BA, Pignone M. Measures used in studies of informed decision making about cancer screening: A systematic review. [Special Issue] Annals of Behavioral Medicine, 2006;32(3):188-201  Collaboration between 6 centers FINDINGS  Most studies measured screening (or intention) and knowledge;  Fewer measured recommended IDM-related constructs  None measured all outcomes proposed for evaluating IDM interventions.

4 Review Recommendations New and in-progress studies:  should emphasize outcomes beyond knowledge –  participation in decision-making according to personal preference  satisfaction with the process, and  consistency between decisions and values.  need better use of theory to guide conceptualization and operationalization of measures  should give greater attention to reliability and validity (particularly in diverse populations)  need more thorough reporting of sources and operating characteristics of measures Funders, researchers, and journal editors should place increased emphasis and resources focused on these issues.

5 Dissemination Forum “Dissemination Research to Promote Cancer Prevention: Methodological Challenges and Approaches” Fall 2007 in Boston, MA  Hosted by Harvard University, Boston University, Dana-Farber Cancer Institute  Planning Committee included members from all 8 CPCRN centers  Over 100 participants attended from diverse backgrounds

6 Dissemination Forum (cont.) AUDIENCE:  Community partners, funders, researchers, students and health practitioners from the Boston area  CPCRN researchers and community partners from other network centers OBJECTIVES:  Review and compare available frameworks to guide dissemination research  Debate the appropriateness of a range of research designs and methods to the key research questions for dissemination research  Identify and discuss challenges to conducting dissemination research across settings  Discuss implications for funding of dissemination research

7 Dissemination Forum (cont.) Products in progress: (1) process for review of dissemination research proposals, instituted following the forum (2) discussion of a plan for a dissemination research resource center; and (3) CPCRN sessions (January 2009):  Society for Behavioral Medicine (SBM) meeting  the National Cancer Institute (NCI) Dissemination Research meeting

8 Multi-center Study “A sustainable approach to increasing cancer screening in community health centers” (Emmons, PI, Bastani, Co-PI)  Collaboration between Harvard and UCLA  Funded by the National Cancer Institute  Goal: develop, implement, and evaluate a telephone reminder system to increase cancer screening rates  Guided by the Chronic Care Model

9 Multi-center Study (cont.) “A sustainable approach to increasing cancer screening in community health centers” (Emmons, PI, Bastani, Co-PI)  Outcomes:  decrease no-show rates at scheduled primary care/screening visits  increase screening rates for breast, cervical, colorectal cancer, and IDM for prostate CA screening.  disseminate Ix to CHCs in Boston and Los Angeles  Evalution of factors influencing adoption and implementation in the dissemination phase  Fills the evidence gap by examining the dissemination of evidence from the Guide

10 Community Guide Cancer Screening Evidence Review Update  Co-leads:Karen Glanz, PhD, MPH (Emory) Randy Elder, PhD (CDC)  Updating cancer screening intervention evidence reviews (breast, cervical, colorectal) for the Guide to Community Preventive Services  Evidence review update spans 2004-2008  Coordination Team and Consultation Teams include representatives from all 8 CPCRN network centers

11 Community Guide Cancer Screening Evidence Review Update  There may be more evidence on invasive procedures for colorectal cancer screening  3 abstractors are working on preliminary search strategies  Using TrialStats software for abstractions/ review management  Using Base Camp knowledge management system for team planning THE GUIDE TO Community PREVENTIVE Services

12 Questions?


Download ppt "Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute."

Similar presentations


Ads by Google